MEETINGS - PharmaMedDevice 2007 (US) April 2007
This article was originally published in Clinica
Executive Summary
PharmaMedDevice 2007, an exhibition and conference targeting the combination product market, will take place during April 24-April 26 2007 at the Jacob K Javits Convention Center, New York, New York. Topics to be addressed at the conference include: molecular and infrared imaging; personalised medicine; virtual instrumentation; vascular tissue engineering; FDA application processes; international regulatory issues; contracts; licensing agreements; and appropriate manufacturing processes. For further details, tel: +1 203 840 5698; fax: +1 203 840 9648; email: [email protected]
You may also be interested in...
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.
Taro Agrees $36m Securities Settlement Over US Price-Fixing Claims
Sun’s Taro subsidiary is looking to move forward with an eight-figure settlement deal in the US, after plaintiffs including a firefighters’ pension fund accused the firm of misleading investors via its involvement in generic price fixing, leading to a fall in the price of its securities.
As Casgevy, Lyfgenia Launches Proceed, CRISPR And bluebird bio CEOs Reassure
The CEOs of bluebird bio and CRISPR Therapeutics hope to inspire investor confidence that their gene-based therapies for sickle cell disease and beta thalassemia will be widely reimbursed in the US and EU.